BCR-ABL V280G Mutation, Potential Role in Imatinib Resistance: First Case Report
{{output}}
Introduction: The identification of BCR-ABL expression as the defining leukemogenic event in chronic myeloid leukemia (CML) and the introduction of BCR-ABL tyrosine kinase inhibitors in 2001 have revolutionized disease management... ...
